Press "Enter" to skip to content

Month: November 2022

Why China’s ‘zero COVID’ policy is finally faltering

For nearly three years now, China has had incredible success at keeping its number of COVID deaths relatively low. So far, the country has recorded only about 6,000 deaths among 1.4 billion people. By comparison, the U.S. has recorded more than a million deaths in a population of only 330 million.

China has accomplished this feat with what’s known as a “zero COVID” policy – using strict lockdowns and community-wide testing and other measures to keep case counts close to nil.

Comments closed

How COVID Truthers Breathed New Life Into an Antisemitic Symbol

The widespread appropriation by COVID truthers of the yellow star that the Nazis forced Jews to wear is a sign that public displays of antisemitism have become normalised in modern Germany to an unthinkable degree, experts say.

Comments closed

How long COVID ruined my life, from crushing fatigue to brain fog

The change struck like a bolt of lightning from a clear blue sky. I’d been under the weather for a couple of weeks – nothing major, just a persistent cough, but for some reason I couldn’t seem to shift it. I took a day off work and carried on. Until 19 March, when I woke up and everything was different.

I was tired – overwhelmingly, crushingly tired, as if I’d been up for days, when in fact I’d slept all night – and I couldn’t think straight. When I tried to text my boss to tell him I wasn’t going to be able to make it into work, it took me more than an hour to string a sentence together.

Eventually, I got out a short apologetic message. Then I went back to bed, where I stayed for three days straight. It should have been scary, but I was too tired to be scared. The need for rest overwhelmed every thought or feeling.

—Rowland Manthorpe
Comments closed

Video | Is COVID-19 Dysregulating Our Immune Systems?

Are people becoming sick more often, experiencing more severe symptoms and having more difficulty treating viral infections after having had COVID-19? If so, why? Epidemiologists,…

Comments closed

Long COVID is ‘not rare’ and can develop after mild illness, says Montreal specialist

The Quebec government is setting up 15 clinics across the province to treat people with long COVID and Lyme disease. The first one to open in Montreal is located at the Jewish General Hospital.

Comments closed

Une nouvelle clinique visant la COVID longue et la maladie de Lyme chronique à Montréal

A clinic dedicated to people with long COVID or persistent symptoms of Lyme disease has just opened at the Jewish General Hospital in Montreal. This reference centre, which will combine clinical and research on these two syndromes still poorly understood, is one of the 15 clinics announced last May by the Ministry of Health and Social Services (MSSS).

“Although we do not yet have a very good understanding of the pathophysiology of these two diseases, we know that both of them sometimes cause long-term sequelae that persist even though the infection seems to have disappeared from the organism,” explains Dr Leighanne Parkes, microbiolgist-infectiologist at this new clinic.

Comments closed

Jewish General Hospital opens long-COVID and Lyme disease clinic

The CIUSSS West-Central Montreal regional health authority announced the opening of a clinic for patients with persistent symptoms of COVID-19 and Lyme disease at the Jewish General Hospital on Monday.

“Although most of the people who get COVID-19 recover within a few weeks, some — even those who had mild versions of the disease — might have symptoms that last a long time afterward,” Dr. Karl Weiss, chief of the Jewish General Hospital’s division of infectious diseases, noted in a statement. “These symptoms can be disabling, making it difficult to perform daily activities or to return to work or school. They may vary in intensity from day to day, and over time.

“Research and knowledge about treating this illness known as long-COVID syndrome is emerging and rapidly evolving. Our goal in establishing the referral centre is to provide patients with leading-edge care, while improving our understanding of the disease.”

Comments closed